BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: McKibben RA, Margolick JB, Grinspoon S, Li X, Palella FJ, Kingsley LA, Witt MD, George RT, Jacobson LP, Budoff M. Elevated levels of monocyte activation markers are associated with subclinical atherosclerosis in men with and those without HIV infection. J Infect Dis. 2015;211:1219-1228. [PMID: 25362192 DOI: 10.1093/infdis/jiu594] [Cited by in Crossref: 113] [Cited by in F6Publishing: 116] [Article Influence: 14.1] [Reference Citation Analysis]
Number Citing Articles
1 Heravi AS, Etzkorn LH, Urbanek JK, Crainiceanu CM, Punjabi NM, Ashikaga H, Brown TT, Budoff MJ, D'Souza G, Magnani JW, Palella FJ Jr, Berger RD, Wu KC, Post WS. HIV Infection Is Associated With Variability in Ventricular Repolarization: The Multicenter AIDS Cohort Study (MACS). Circulation 2020;141:176-87. [PMID: 31707799 DOI: 10.1161/CIRCULATIONAHA.119.043042] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
2 Nou E, Lo J, Grinspoon SK. Inflammation, immune activation, and cardiovascular disease in HIV. AIDS 2016;30:1495-509. [PMID: 27058351 DOI: 10.1097/QAD.0000000000001109] [Cited by in Crossref: 95] [Cited by in F6Publishing: 56] [Article Influence: 19.0] [Reference Citation Analysis]
3 . International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK. J Int AIDS Soc 2016;19:21487. [PMID: 27780519 DOI: 10.7448/IAS.19.8.21487] [Cited by in Crossref: 11] [Article Influence: 1.8] [Reference Citation Analysis]
4 Feinstein MJ, Bogorodskaya M, Bloomfield GS, Vedanthan R, Siedner MJ, Kwan GF, Longenecker CT. Cardiovascular Complications of HIV in Endemic Countries. Curr Cardiol Rep 2016;18:113. [PMID: 27730474 DOI: 10.1007/s11886-016-0794-x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
5 Walker JA, Miller AD, Burdo TH, McGrath MS, Williams KC. Direct Targeting of Macrophages With Methylglyoxal-Bis-Guanylhydrazone Decreases SIV-Associated Cardiovascular Inflammation and Pathology. J Acquir Immune Defic Syndr 2017;74:583-92. [PMID: 28141779 DOI: 10.1097/QAI.0000000000001297] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
6 Brusca RM, Hanna DB, Wada NI, Blankson JN, Witt MD, Jacobson LP, Kingsley L, Palella FJ Jr, Budoff M, Brown TT, Anastos K, Lazar JM, Mack WJ, Bacchetti P, Tien PC, Golzar Y, Plankey M, Golub E, Kaplan RC, Post WS. Subclinical cardiovascular disease in HIV controller and long-term nonprogressor populations. HIV Med 2020;21:217-27. [PMID: 31729142 DOI: 10.1111/hiv.12820] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
7 Shah MR, Wong RP. The Changing Paradigm of HIV-Related Heart Failure. Glob Heart 2015;10:241-4. [PMID: 26704962 DOI: 10.1016/j.gheart.2015.09.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
8 Dubé MP, Chan ES, Lake JE, Williams B, Kinslow J, Landay A, Coombs RW, Floris-Moore M, Ribaudo HJ, Yarasheski KE. A Randomized, Double-blinded, Placebo-controlled Trial of Sitagliptin for Reducing Inflammation and Immune Activation in Treated and Suppressed Human Immunodeficiency Virus Infection. Clin Infect Dis 2019;69:1165-72. [PMID: 30535188 DOI: 10.1093/cid/ciy1051] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
9 Lakritz JR, Robinson JA, Polydefkis MJ, Miller AD, Burdo TH. Loss of intraepidermal nerve fiber density during SIV peripheral neuropathy is mediated by monocyte activation and elevated monocyte chemotactic proteins. J Neuroinflammation 2015;12:237. [PMID: 26683323 DOI: 10.1186/s12974-015-0456-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
10 Bhatia NS, Chow FC. Neurologic Complications in Treated HIV-1 Infection. Curr Neurol Neurosci Rep 2016;16:62. [PMID: 27170369 DOI: 10.1007/s11910-016-0666-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
11 Castillo-Mancilla JR, Phillips AN, Neaton JD, Neuhaus J, Collins S, Mannheimer S, Pett S, Touzeau-Römer V, Polizzotto MN, Lundgren JD, Gardner EM; INSIGHT SMART Study Group. Association of Suboptimal Antiretroviral Therapy Adherence With Inflammation in Virologically Suppressed Individuals Enrolled in the SMART Study. Open Forum Infect Dis 2018;5:ofx275. [PMID: 29362724 DOI: 10.1093/ofid/ofx275] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
12 Volpe M, Uglietti A, Castagna A, Mussini C, Marchetti G, Bellagamba R, Bini T, Mancusi D, Termini R. Cardiovascular disease in women with HIV-1 infection. Int J Cardiol 2017;241:50-6. [PMID: 28285796 DOI: 10.1016/j.ijcard.2017.02.117] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
13 Stanislawski MA, Lange LA, Raffield LM, Zakai NA, Meyer M, Ferrier K, Szeto MD, Leavitt C, Shortt JA, Thornton TA, Tracy RP, Auer PL, Reiner AP, Lange EM, Olson NC. Soluble CD14 Levels in the Jackson Heart Study: Associations With Cardiovascular Disease Risk and Genetic Variants. Arterioscler Thromb Vasc Biol 2021;41:e369-78. [PMID: 33910371 DOI: 10.1161/ATVBAHA.121.316035] [Reference Citation Analysis]
14 Ruiz-Briseño MDR, De Arcos-Jiménez JC, Ratkovich-González S, Sánchez-Reyes K, González-Hernández LA, Andrade-Villanueva JF, Alvarez-Zavala M. Association of intestinal and systemic inflammatory biomarkers with immune reconstitution in HIV+ patients on ART. J Inflamm (Lond) 2020;17:32. [PMID: 33071649 DOI: 10.1186/s12950-020-00262-4] [Reference Citation Analysis]
15 Oikonomidis N, Kavantzas N, Korou LM, Konstantopoulos P, Pergialiotis V, Misiakos E, Rizos I, Verikokos C, Perrea DN. Pre-treatment with simvastatin prevents the induction of diet-induced atherosclerosis in a rabbit model. Biomed Rep 2016;5:667-74. [PMID: 28101339 DOI: 10.3892/br.2016.780] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
16 Feinstein MJ, Doyle MF, Stein JH, Sitlani CM, Fohner AE, Huber SA, Landay AL, Heckbert SR, Rice K, Kronmal RA, Hedrick C, Manichaikul A, McNamara C, Rich S, Tracy RP, Olson NC, Psaty BM, Delaney JAC. Nonclassical Monocytes (CD14dimCD16+) Are Associated With Carotid Intima-Media Thickness Progression for Men but Not Women: The Multi-Ethnic Study of Atherosclerosis-Brief Report. Arterioscler Thromb Vasc Biol 2021;41:1810-7. [PMID: 33761764 DOI: 10.1161/ATVBAHA.120.315886] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Kirkegaard-Klitbo DM, Mejer N, Knudsen TB, Møller HJ, Moestrup SK, Poulsen SD, Kronborg G, Benfield T. Soluble CD163 predicts incident chronic lung, kidney and liver disease in HIV infection. AIDS 2017;31:981-8. [PMID: 28252527 DOI: 10.1097/QAD.0000000000001432] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
18 Mueller MC, Kern WV, Usadel S, Pauly MC, Cathomen T, Salzer U. Assessing the differential impact of chronic CMV and treated HIV infection on CD8+ T-cell differentiation in a matched cohort study: is CMV the key? AIDS Res Ther 2021;18:37. [PMID: 34193181 DOI: 10.1186/s12981-021-00361-z] [Reference Citation Analysis]
19 Temu TM, Polyak SJ, Zifodya JS, Wanjalla CN, Koethe JR, Masyuko S, Nyabiage J, Kinuthia J, Gervassi AL, Oyugi J, Page S, Farquhar C. Endothelial Dysfunction Is Related to Monocyte Activation in Antiretroviral-Treated People With HIV and HIV-Negative Adults in Kenya. Open Forum Infect Dis 2020;7:ofaa425. [PMID: 33094120 DOI: 10.1093/ofid/ofaa425] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Titanji B, Gavegnano C, Hsue P, Schinazi R, Marconi VC. Targeting Inflammation to Reduce Atherosclerotic Cardiovascular Risk in People With HIV Infection. J Am Heart Assoc 2020;9:e014873. [PMID: 31973607 DOI: 10.1161/JAHA.119.014873] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
21 Rezaeian P, Miller PE, Haberlen SA, Razipour A, Bahrami H, Castillo R, Witt MD, Kingsley L, Palella FJ Jr, Nakanishi R, Matsumoto S, Alani A, Jacobson LP, Post WS, Budoff MJ. Extra-coronary calcification (aortic valve calcification, mitral annular calcification, aortic valve ring calcification and thoracic aortic calcification) in HIV seropositive and seronegative men: Multicenter AIDS Cohort Study. J Cardiovasc Comput Tomogr 2016;10:229-36. [PMID: 26949197 DOI: 10.1016/j.jcct.2016.02.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
22 Raghavan A, Rimmelin DE, Fitch KV, Zanni MV. Sex Differences in Select Non-communicable HIV-Associated Comorbidities: Exploring the Role of Systemic Immune Activation/Inflammation. Curr HIV/AIDS Rep 2017;14:220-8. [PMID: 29080122 DOI: 10.1007/s11904-017-0366-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 6.3] [Reference Citation Analysis]
23 McGettrick P, Barco EA, Mallon PWG. Ageing with HIV. Healthcare (Basel) 2018;6:E17. [PMID: 29443936 DOI: 10.3390/healthcare6010017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
24 Siedner MJ, Kim JH, Nakku RS, Bibangambah P, Hemphill L, Triant VA, Haberer JE, Martin JN, Mocello AR, Boum Y 2nd, Kwon DS, Tracy RP, Burdo T, Huang Y, Cao H, Okello S, Bangsberg DR, Hunt PW. Persistent Immune Activation and Carotid Atherosclerosis in HIV-Infected Ugandans Receiving Antiretroviral Therapy. J Infect Dis 2016;213:370-8. [PMID: 26347573 DOI: 10.1093/infdis/jiv450] [Cited by in Crossref: 48] [Cited by in F6Publishing: 51] [Article Influence: 6.9] [Reference Citation Analysis]
25 Mwakyandile T, Shayo G, Mugusi S, Sunguya B, Sasi P, Moshiro C, Mugusi F, Lyamuya E. Effect of aspirin on HIV disease progression among HIV-infected individuals initiating antiretroviral therapy: study protocol for a randomised controlled trial. BMJ Open 2021;11:e049330. [PMID: 34728445 DOI: 10.1136/bmjopen-2021-049330] [Reference Citation Analysis]
26 Desai SN, Landay AL. HIV and aging: role of the microbiome. Curr Opin HIV AIDS 2018;13:22-7. [PMID: 29035948 DOI: 10.1097/COH.0000000000000433] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 3.8] [Reference Citation Analysis]
27 Castley A, Williams L, James I, Guelfi G, Berry C, Nolan D. Plasma CXCL10, sCD163 and sCD14 Levels Have Distinct Associations with Antiretroviral Treatment and Cardiovascular Disease Risk Factors. PLoS One 2016;11:e0158169. [PMID: 27355513 DOI: 10.1371/journal.pone.0158169] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
28 Hileman CO, Turner R, Funderburg NT, Semba RD, McComsey GA. Changes in oxidized lipids drive the improvement in monocyte activation and vascular disease after statin therapy in HIV. AIDS 2016;30:65-73. [PMID: 26731754 DOI: 10.1097/QAD.0000000000000885] [Cited by in Crossref: 14] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
29 Toribio M, Park MH, Zanni MV, Robbins GK, Burdo TH, Williams KC, Feldpausch MN, Stone L, Melbourne K, Grinspoon SK, Fitzgerald ML. HDL Cholesterol Efflux Capacity in Newly Diagnosed HIV and Effects of Antiretroviral Therapy. J Clin Endocrinol Metab 2017;102:4250-9. [PMID: 28945911 DOI: 10.1210/jc.2017-01334] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
30 Hall LN, Sanchez LR, Hubbard J, Lee H, Looby SE, Srinivasa S, Zanni MV, Stanley TL, Lo J, Grinspoon SK, Fitch KV. Aspartame Intake Relates to Coronary Plaque Burden and Inflammatory Indices in Human Immunodeficiency Virus. Open Forum Infect Dis 2017;4:ofx083. [PMID: 28695142 DOI: 10.1093/ofid/ofx083] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
31 Siegel PM, Sander L, Fricke A, Stamm J, Wang X, Sharma P, Bassler N, Ying YL, Olivier CB, Eisenhardt SU, Bode C, Ahrens I, Diehl P, Peter K. P2Y12 receptor blockers are anti-inflammatory drugs inhibiting both circulating monocytes and macrophages including THP-1 cells. Sci Rep 2021;11:17459. [PMID: 34465804 DOI: 10.1038/s41598-021-95710-3] [Reference Citation Analysis]
32 Martin-Iguacel R, Llibre JM, Friis-Moller N. Risk of Cardiovascular Disease in an Aging HIV Population: Where Are We Now? Curr HIV/AIDS Rep 2015;12:375-87. [PMID: 26423407 DOI: 10.1007/s11904-015-0284-6] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 6.8] [Reference Citation Analysis]
33 Raju S, McCormack MC. Defining the Link between Pulmonary and Cardiovascular Disease for People Living with Human Immunodeficiency Virus. Ann Am Thorac Soc 2019;16:672-3. [PMID: 31149854 DOI: 10.1513/AnnalsATS.201903-238ED] [Reference Citation Analysis]
34 Carrera-Bastos P, Picazo Ó, Fontes-Villalba M, Pareja-Galeano H, Lindeberg S, Martínez-Selles M, Lucia A, Emanuele E. Serum Zonulin and Endotoxin Levels in Exceptional Longevity versus Precocious Myocardial Infarction. Aging Dis 2018;9:317-21. [PMID: 29896420 DOI: 10.14336/AD.2017.0630] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
35 Longenecker CT, Sullivan C, Baker JV. Immune activation and cardiovascular disease in chronic HIV infection. Curr Opin HIV AIDS 2016;11:216-25. [PMID: 26599166 DOI: 10.1097/COH.0000000000000227] [Cited by in Crossref: 40] [Cited by in F6Publishing: 32] [Article Influence: 6.7] [Reference Citation Analysis]
36 Ziaee S, Boroumand MA, Salehi R, Sadeghian S, Hosseindokht M, Sharifi M. Non-invasive diagnosis of early-onset coronary artery disease based on cell type-specific gene expression analyses. Biomed Pharmacother 2018;108:1115-22. [PMID: 30372812 DOI: 10.1016/j.biopha.2018.09.134] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
37 Sinha A, Ma Y, Scherzer R, Rahalkar S, Neilan BD, Crane H, Drozd D, Martin J, Deeks SG, Hunt P, Hsue PY. Carnitine Is Associated With Atherosclerotic Risk and Myocardial Infarction in HIV -Infected Adults. J Am Heart Assoc 2019;8:e011037. [PMID: 31030595 DOI: 10.1161/JAHA.118.011037] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
38 Stone L, Looby SE, Zanni MV. Cardiovascular disease risk among women living with HIV in North America and Europe. Curr Opin HIV AIDS 2017;12:585-93. [PMID: 28832367 DOI: 10.1097/COH.0000000000000413] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
39 Generoso M, Álvarez P, Kravietz A, Mwamzuka M, Marshed F, Ahmed A, Khaitan A. High soluble CD163 levels correlate with disease progression and inflammation in Kenyan children with perinatal HIV-infection. AIDS 2020;34:33-8. [PMID: 31567161 DOI: 10.1097/QAD.0000000000002378] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Poudel KC, Bertone-Johnson ER, Poudel-Tandukar K. Serum Zinc Concentration and C-Reactive Protein in Individuals with Human Immunodeficiency Virus Infection: the Positive Living with HIV (POLH) Study. Biol Trace Elem Res 2016;171:63-70. [PMID: 26429417 DOI: 10.1007/s12011-015-0520-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
41 Machado de Carvalho M, Donato Fook K, José Abigail Mendes Araújo M, Janayna Araújo Guimarães S, Penha Abreu Souza C, Déa Trindade Barbosa C, Cléa Cutrim Diniz de Morais A, Costa de Sales Muniz A, Rocha de Araújo D, Bezerra Lima Bertolaccini MF, Kassandra Pereira Belfort I, de Souza Andrade M, Cristina Moutinho Monteiro S. Prevalence of Dyslipidemia in HIV-Positive Women with HPV Coinfection: A Preliminary Study. Scientifica (Cairo) 2021;2021:4318423. [PMID: 34765266 DOI: 10.1155/2021/4318423] [Reference Citation Analysis]
42 Feinstein MJ, Hsue PY, Benjamin LA, Bloomfield GS, Currier JS, Freiberg MS, Grinspoon SK, Levin J, Longenecker CT, Post WS. Characteristics, Prevention, and Management of Cardiovascular Disease in People Living With HIV: A Scientific Statement From the American Heart Association. Circulation 2019;140:e98-e124. [PMID: 31154814 DOI: 10.1161/CIR.0000000000000695] [Cited by in Crossref: 123] [Cited by in F6Publishing: 66] [Article Influence: 41.0] [Reference Citation Analysis]
43 Patel AA, Budoff MJ. Coronary Artery Disease in Patients with HIV Infection: An Update. Am J Cardiovasc Drugs 2021;21:411-7. [PMID: 33184766 DOI: 10.1007/s40256-020-00451-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
44 Abelman RA, Mugo BM, Zanni MV. Conceptualizing the Risks of Coronary Heart Disease and Heart Failure Among People Aging with HIV: Sex-Specific Considerations. Curr Treat Options Cardio Med 2019;21. [DOI: 10.1007/s11936-019-0744-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
45 Subramanya V, McKay HS, Brusca RM, Palella FJ, Kingsley LA, Witt MD, Hodis HN, Tracy RP, Post WS, Haberlen SA. Inflammatory biomarkers and subclinical carotid atherosclerosis in HIV-infected and HIV-uninfected men in the Multicenter AIDS Cohort Study. PLoS One 2019;14:e0214735. [PMID: 30946765 DOI: 10.1371/journal.pone.0214735] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
46 Dumond JB, Bay CP, Nelson JAE, Davalos A, Edmonds A, De Paris K, Sykes C, Anastos K, Sharma R, Kassaye S, Tamraz B, French AL, Gange S, Ofotokun I, Fischl MA, Vance DE, Adimora AA. Intracellular Tenofovir and Emtricitabine Concentrations in Younger and Older Women with HIV Receiving Tenofovir Disoproxil Fumarate/Emtricitabine. Antimicrob Agents Chemother 2020;64:e00177-20. [PMID: 32631821 DOI: 10.1128/AAC.00177-20] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
47 López-Dupla M, Maymó-Masip E, Martínez E, Domingo P, Leal M, Peraire J, Viladés C, Veloso S, Arnedo M, Ferrando-Martínez S, Beltrán-Debón R, Alba V, Gatell JM, Vendrell J, Vidal F, Chacón MR. HIV-1/HAART-Related Lipodystrophy Syndrome (HALS) Is Associated with Decreased Circulating sTWEAK Levels. PLoS One 2015;10:e0144789. [PMID: 26658801 DOI: 10.1371/journal.pone.0144789] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
48 Erlandson KM, Campbell TB. Inflammation in Chronic HIV Infection: What Can We Do? J Infect Dis 2015;212:339-42. [DOI: 10.1093/infdis/jiv007] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
49 Baroncelli S, Galluzzo CM, Liotta G, Andreotti M, Ciccacci F, Mancinelli S, Tolno VT, Gondwe J, Amici R, Marazzi MC, Vella S, Giuliano M, Palombi L, Palmisano L. Soluble CD14 levels in plasma and breastmilk of Malawian HIV+ women: Lack of association with morbidity and mortality in their exposed infants. Am J Reprod Immunol 2018;79. [PMID: 29323435 DOI: 10.1111/aji.12812] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
50 Bahrami H, Budoff M, Haberlen SA, Rezaeian P, Ketlogetswe K, Tracy R, Palella F, Witt MD, McConnell MV, Kingsley L, Post WS. Inflammatory Markers Associated With Subclinical Coronary Artery Disease: The Multicenter AIDS Cohort Study. J Am Heart Assoc 2016;5:e003371. [PMID: 27353609 DOI: 10.1161/JAHA.116.003371] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 6.0] [Reference Citation Analysis]
51 Hodowanec A, Williams B, Hanson B, Livak B, Keating S, Lurain N, Adeyemi OM. Soluble CD163 But Not Soluble CD14 Is Associated With Cytomegalovirus Immunoglobulin G Antibody Levels in Virologically Suppressed HIV+ Individuals. J Acquir Immune Defic Syndr 2015;70:e171-4. [PMID: 26569178 DOI: 10.1097/QAI.0000000000000841] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
52 Thomas GP, Li X, Post WS, Jacobson LP, Witt MD, Brown TT, Kingsley LA, Phair JP, Palella FJ Jr. Associations between antiretroviral use and subclinical coronary atherosclerosis. AIDS 2016;30:2477-86. [PMID: 27490639 DOI: 10.1097/QAD.0000000000001220] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 2.6] [Reference Citation Analysis]
53 Omoike OE, Pack RP, Mamudu HM, Liu Y, Strasser S, Zheng S, Okoro J, Wang L. Association between per and polyfluoroalkyl substances and markers of inflammation and oxidative stress. Environ Res 2021;196:110361. [PMID: 33131681 DOI: 10.1016/j.envres.2020.110361] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
54 Knudsen TB, Ertner G, Petersen J, Møller HJ, Moestrup SK, Eugen-Olsen J, Kronborg G, Benfield T. Plasma Soluble CD163 Level Independently Predicts All-Cause Mortality in HIV-1-Infected Individuals. J Infect Dis 2016;214:1198-204. [PMID: 27354366 DOI: 10.1093/infdis/jiw263] [Cited by in Crossref: 70] [Cited by in F6Publishing: 75] [Article Influence: 11.7] [Reference Citation Analysis]
55 Monroe AK, Haberlen SA, Post WS, Palella FJ Jr, Kinsgley LA, Witt MD, Budoff M, Jacobson LP, Brown TT. Cardiovascular disease risk scores' relationship to subclinical cardiovascular disease among HIV-infected and HIV-uninfected men. AIDS 2016;30:2075-84. [PMID: 27203714 DOI: 10.1097/QAD.0000000000001163] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
56 Sinha A, Ma Y, Scherzer R, Hur S, Li D, Ganz P, Deeks SG, Hsue PY. Role of T-Cell Dysfunction, Inflammation, and Coagulation in Microvascular Disease in HIV. J Am Heart Assoc 2016;5:e004243. [PMID: 27998918 DOI: 10.1161/JAHA.116.004243] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
57 Castillo-Mancilla JR, Brown TT, Erlandson KM, Palella FJ Jr, Gardner EM, Macatangay BJ, Breen EC, Jacobson LP, Anderson PL, Wada NI. Suboptimal Adherence to Combination Antiretroviral Therapy Is Associated With Higher Levels of Inflammation Despite HIV Suppression. Clin Infect Dis 2016;63:1661-7. [PMID: 27660234 DOI: 10.1093/cid/ciw650] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 7.7] [Reference Citation Analysis]
58 O'Brien MP, Zafar MU, Rodriguez JC, Okoroafor I, Heyison A, Cavanagh K, Rodriguez-Caprio G, Weinberg A, Escolar G, Aberg JA, Badimon JJ. Targeting thrombogenicity and inflammation in chronic HIV infection. Sci Adv 2019;5:eaav5463. [PMID: 31206016 DOI: 10.1126/sciadv.aav5463] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
59 Siedner MJ, Triant V. Undetectable = Untransmittable and Your Health: The Personal Benefits of Early and Continuous Therapy for HIV Infection. J Infect Dis 2019;219:173-6. [PMID: 30032272 DOI: 10.1093/infdis/jiy445] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
60 Van Epps P, Kalayjian RC. Human Immunodeficiency Virus and Aging in the Era of Effective Antiretroviral Therapy. Infectious Disease Clinics of North America 2017;31:791-810. [DOI: 10.1016/j.idc.2017.07.007] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 6.2] [Reference Citation Analysis]
61 Chan P, Spudich S. Investigating vascular diseases in people living with HIV by nuclear imaging. J Nucl Cardiol 2021. [PMID: 33884573 DOI: 10.1007/s12350-021-02613-x] [Reference Citation Analysis]
62 Luo L, Han Y, Song X, Zhu T, Zeng Y, Li T. CD16-expressing monocytes correlate with arterial stiffness in HIV-infected ART-naïve men. HIV Clin Trials 2018;19:39-45. [PMID: 29770747 DOI: 10.1080/15284336.2018.1437863] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
63 Hanna DB, Lin J, Post WS, Hodis HN, Xue X, Anastos K, Cohen MH, Gange SJ, Haberlen SA, Heath SL, Lazar JM, Liu C, Mack WJ, Ofotokun I, Palella FJ, Tien PC, Witt MD, Landay AL, Kingsley LA, Tracy RP, Kaplan RC. Association of Macrophage Inflammation Biomarkers With Progression of Subclinical Carotid Artery Atherosclerosis in HIV-Infected Women and Men. J Infect Dis 2017;215:1352-61. [PMID: 28199691 DOI: 10.1093/infdis/jix082] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 11.2] [Reference Citation Analysis]
64 [DOI: 10.1101/412312] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
65 Tincati C, Merlini E, Ancona G, Marchetti G. Biomarkers of aging in HIV: inflammation and the microbiome. Eur Geriatr Med 2019;10:175-82. [PMID: 34652744 DOI: 10.1007/s41999-018-0145-0] [Reference Citation Analysis]
66 Alencherry B, Erem G, Mirembe G, Ssinabulya I, Yun CH, Hung CL, Siedner MJ, Bittencourt M, Kityo C, McComsey GA, Longenecker CT. Coronary artery calcium, HIV and inflammation in Uganda compared with the USA. Open Heart 2019;6:e001046. [PMID: 31218009 DOI: 10.1136/openhrt-2019-001046] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
67 Akiyama H, Gummuluru S. HIV-1 Persistence and Chronic Induction of Innate Immune Responses in Macrophages. Viruses 2020;12:E711. [PMID: 32630058 DOI: 10.3390/v12070711] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
68 van den Dries L, Claassen MAA, Groothuismink ZMA, van Gorp E, Boonstra A. Immune activation in prolonged cART-suppressed HIV patients is comparable to that of healthy controls. Virology 2017;509:133-9. [PMID: 28644978 DOI: 10.1016/j.virol.2017.06.014] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
69 Toribio M, Fitch KV, Sanchez L, Burdo TH, Williams KC, Sponseller CA, McCurdy Pate M, Aberg JA, Zanni MV, Grinspoon SK. Effects of pitavastatin and pravastatin on markers of immune activation and arterial inflammation in HIV. AIDS 2017;31:797-806. [PMID: 28252528 DOI: 10.1097/QAD.0000000000001427] [Cited by in Crossref: 50] [Cited by in F6Publishing: 34] [Article Influence: 12.5] [Reference Citation Analysis]
70 Ma P, Luo Z, Qian J, Yan Z, Zhang L, Martin L, Wang Z, Xia H, Yu F, Jiang W. Decreased ratio of influenza-specific IgG versus IgM in response to influenza vaccination in antiretroviral-treated HIV-infected African Americans compared to Caucasians, and its direct correlation with the percentages of peripheral Tfh cells. Vaccine 2020;38:1998-2004. [PMID: 31948820 DOI: 10.1016/j.vaccine.2020.01.002] [Reference Citation Analysis]
71 Nou E, Lo J, Hadigan C, Grinspoon SK. Pathophysiology and management of cardiovascular disease in patients with HIV. Lancet Diabetes Endocrinol 2016;4:598-610. [PMID: 26873066 DOI: 10.1016/S2213-8587(15)00388-5] [Cited by in Crossref: 45] [Cited by in F6Publishing: 26] [Article Influence: 7.5] [Reference Citation Analysis]
72 Korada SKC, Zhao D, Tibuakuu M, Brown TT, Jacobson LP, Guallar E, Bolan RK, Palella FJ, Margolick JB, Martinson JJ, Budoff MJ, Post WS, Michos ED. Frailty and subclinical coronary atherosclerosis: The Multicenter AIDS Cohort Study (MACS). Atherosclerosis 2017;266:240-7. [PMID: 28886899 DOI: 10.1016/j.atherosclerosis.2017.08.026] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
73 Tibuakuu M, Fashanu OE, Zhao D, Otvos JD, Brown TT, Haberlen SA, Guallar E, Budoff MJ, Palella FJ Jr, Martinson JJ, Akinkuolie AO, Mora S, Post WS, Michos ED. GlycA, a novel inflammatory marker, is associated with subclinical coronary disease. AIDS 2019;33:547-57. [PMID: 30475263 DOI: 10.1097/QAD.0000000000002079] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
74 Mayne ES, George JA. Mortal allies: human immunodeficiency virus and noncommunicable diseases. Curr Opin HIV AIDS 2017;12:148-56. [PMID: 28134710 DOI: 10.1097/COH.0000000000000342] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
75 Cai CW, Sereti I. Residual immune dysfunction under antiretroviral therapy. Semin Immunol 2021;:101471. [PMID: 33674177 DOI: 10.1016/j.smim.2021.101471] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
76 Siedner MJ, Bibangambah P, Kim JH, Lankowski A, Chang JL, Yang IT, Kwon DS, North CM, Triant VA, Longenecker C, Ghoshhajra B, Peck RN, Sentongo RN, Gilbert R, Kakuhikire B, Boum Y 2nd, Haberer JE, Martin JN, Tracy R, Hunt PW, Bangsberg DR, Tsai AC, Hemphill LC, Okello S. Treated HIV Infection and Progression of Carotid Atherosclerosis in Rural Uganda: A Prospective Observational Cohort Study. J Am Heart Assoc 2021;10:e019994. [PMID: 34096320 DOI: 10.1161/JAHA.120.019994] [Reference Citation Analysis]
77 Maia-Leite LH, Catez E, Boyd A, Haddour N, Curjol A, Lang S, Nuernberg M, Duvivier C, Desvarieux M, Kirstetter M, Girard PM, Cohen A, Boccara F. Aortic stiffness aging is influenced by past profound immunodeficiency in HIV-infected individuals: results from the EVAS-HIV (EValuation of Aortic Stiffness in HIV-infected individuals). J Hypertens 2016;34:1338-46. [PMID: 27137177 DOI: 10.1097/HJH.0000000000000957] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
78 Yadav A, Betts MR, Collman RG. Statin modulation of monocyte phenotype and function: implications for HIV-1-associated neurocognitive disorders. J Neurovirol 2016;22:584-96. [PMID: 27021071 DOI: 10.1007/s13365-016-0433-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
79 Shahbaz S, Manicardi M, Guaraldi G, Raggi P. Cardiovascular disease in human immunodeficiency virus infected patients: A true or perceived risk? World J Cardiol 2015; 7(10): 633-644 [PMID: 26516417 DOI: 10.4330/wjc.v7.i10.633] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
80 Kelly SG, Wu K, Tassiopoulos K, Erlandson KM, Koletar SL, Palella FJ Jr; ACTG A5322 Study Team. Incorporating Frailty Into the Pooled Cohort Equations to Predict Cardiovascular Disease Among Persons With HIV. J Acquir Immune Defic Syndr 2021;87:971-7. [PMID: 33625065 DOI: 10.1097/QAI.0000000000002662] [Reference Citation Analysis]
81 Lin L, Li TS. Multidisciplinary collaborative integrated management of increasingly prominent HIV complications in the post-cART era. HIV Med 2020;21:683-91. [PMID: 33369030 DOI: 10.1111/hiv.13022] [Reference Citation Analysis]
82 Belkina AC, Starchenko A, Drake KA, Proctor EA, Pihl RMF, Olson A, Lauffenburger DA, Lin N, Snyder-Cappione JE. Multivariate Computational Analysis of Gamma Delta T Cell Inhibitory Receptor Signatures Reveals the Divergence of Healthy and ART-Suppressed HIV+ Aging. Front Immunol 2018;9:2783. [PMID: 30568654 DOI: 10.3389/fimmu.2018.02783] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
83 Fitch KV, DeFilippi C, Christenson R, Srinivasa S, Lee H, Lo J, Lu MT, Wong K, Petrow E, Sanchez L, Looby SE, Hoffmann U, Zanni M, Grinspoon SK. Subclinical myocyte injury, fibrosis and strain in relationship to coronary plaque in asymptomatic HIV-infected individuals. AIDS 2016;30:2205-14. [PMID: 27314177 DOI: 10.1097/QAD.0000000000001186] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 3.4] [Reference Citation Analysis]
84 Olson NC, Koh I, Reiner AP, Judd SE, Irvin MR, Howard G, Zakai NA, Cushman M. Soluble CD14, Ischemic Stroke, and Coronary Heart Disease Risk in a Prospective Study: The REGARDS Cohort. J Am Heart Assoc 2020;9:e014241. [PMID: 32157955 DOI: 10.1161/JAHA.119.014241] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
85 Lake JE, Clark JL. Optimizing HIV prevention and care for transgender adults. AIDS 2019;33:363-75. [PMID: 30703068 DOI: 10.1097/QAD.0000000000002095] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
86 McGettrick P, Mallon PWG. Biomarkers to predict cardiovascular disease in people living with HIV. Curr Opin Infect Dis 2022;35:15-20. [PMID: 34873078 DOI: 10.1097/QCO.0000000000000802] [Reference Citation Analysis]
87 Anderson AM, Bhondoekhan F, Curanovic D, Connelly MA, Otvos JD, Post WS, Michos ED, Lahiri C, Wolinsky S, Levine A, Seaberg EC, Rubin LH, Vance DE, Becker JT. GlycA is associated with neuropsychological impairment in men with HIV. AIDS 2022;36:156-9. [PMID: 34873097 DOI: 10.1097/QAD.0000000000003094] [Reference Citation Analysis]
88 Dirajlal-Fargo S, Alam K, Sattar A, Kulkarni M, Funderburg N, Wilson WH, McComsey GA. Comprehensive assessment of the arginine pathway and its relationship to inflammation in HIV. AIDS 2017;31:533-7. [PMID: 27922857 DOI: 10.1097/QAD.0000000000001363] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
89 van der Heijden WA, Van de Wijer L, Keramati F, Trypsteen W, Rutsaert S, Horst RT, Jaeger M, Koenen HJ, Stunnenberg HG, Joosten I, Verweij PE, van Lunzen J, Dinarello CA, Joosten LA, Vandekerckhove L, Netea MG, van der Ven AJ, de Mast Q. Chronic HIV infection induces transcriptional and functional reprogramming of innate immune cells. JCI Insight 2021;6:145928. [PMID: 33630761 DOI: 10.1172/jci.insight.145928] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
90 Kearns A, Gordon J, Burdo TH, Qin X. HIV-1-Associated Atherosclerosis: Unraveling the Missing Link. J Am Coll Cardiol 2017;69:3084-98. [PMID: 28641798 DOI: 10.1016/j.jacc.2017.05.012] [Cited by in Crossref: 69] [Cited by in F6Publishing: 68] [Article Influence: 13.8] [Reference Citation Analysis]
91 Tawakol A, Grinspoon SK. Imaging atherosclerotic burden and inflammation: insights into the spectrum of atherosclerotic disease in HIV. J Nucl Cardiol 2015;22:381-4. [PMID: 25537613 DOI: 10.1007/s12350-014-0044-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
92 Krikke M, Tesselaar K, van den Berk GEL, Otto SA, Freriks LH, van Lelyveld SFL, Visseren FJL, Hoepelman AIM, Arends JE. The effect of switching protease inhibitors to raltegravir on endothelial function, in HIV-infected patients. HIV Clin Trials 2018;19:75-83. [PMID: 29770748 DOI: 10.1080/15284336.2018.1455366] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
93 Yadav A, Kossenkov AV, Knecht VR, Showe LC, Ratcliffe SJ, Montaner LJ, Tebas P, Collman RG. Evidence for Persistent Monocyte and Immune Dysregulation After Prolonged Viral Suppression Despite Normalization of Monocyte Subsets, sCD14 and sCD163 in HIV-Infected Individuals. Pathog Immun 2019;4:324-62. [PMID: 31893252 DOI: 10.20411/pai.v4i2.336] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
94 Lacey A, Savinelli S, Barco EA, Macken A, Cotter AG, Sheehan G, Lambert JS, Muldoon E, Feeney E, Mallon PW, Tinago W; UCD ID Cohort Study. Investigating the effect of antiretroviral switch to tenofovir alafenamide on lipid profiles in people living with HIV. AIDS 2020;34:1161-70. [PMID: 32310899 DOI: 10.1097/QAD.0000000000002541] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 13.0] [Reference Citation Analysis]
95 Murray KD, Singh MV, Zhuang Y, Uddin MN, Qiu X, Weber MT, Tivarus ME, Wang HZ, Sahin B, Zhong J, Maggirwar SB, Schifitto G. Pathomechanisms of HIV-Associated Cerebral Small Vessel Disease: A Comprehensive Clinical and Neuroimaging Protocol and Analysis Pipeline. Front Neurol 2020;11:595463. [PMID: 33384655 DOI: 10.3389/fneur.2020.595463] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
96 Bogorodskaya M, Lyass A, Mahoney TF, Borowsky LH, Sen P, Swirski FK, Srinivasa S, Longenecker CT, Massaro JM, D'Agostino RB Sr, Triant VA. Utilization of absolute monocyte counts to predict cardiovascular events in people living with HIV. HIV Med 2021;22:314-20. [PMID: 33295150 DOI: 10.1111/hiv.13018] [Reference Citation Analysis]
97 Laurence J, Elhadad S, Ahamed J. HIV-associated cardiovascular disease: importance of platelet activation and cardiac fibrosis in the setting of specific antiretroviral therapies. Open Heart 2018;5:e000823. [PMID: 30018781 DOI: 10.1136/openhrt-2018-000823] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 4.8] [Reference Citation Analysis]
98 Mørch RH, Dieset I, Færden A, Reponen EJ, Hope S, Hoseth EZ, Gardsjord ES, Aas M, Iversen T, Joa I, Morken G, Agartz I, Melle I, Aukrust P, Djurovic S, Ueland T, Andreassen OA. Inflammatory markers are altered in severe mental disorders independent of comorbid cardiometabolic disease risk factors. Psychol Med 2019;49:1749-57. [PMID: 30688187 DOI: 10.1017/S0033291718004142] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 4.7] [Reference Citation Analysis]
99 Castillo-Mancilla JR, Morrow M, Boum Y, Byakwaga H, Haberer JE, Martin JN, Bangsberg D, Mawhinney S, Musinguzi N, Huang Y, Tracy RP, Burdo TH, Williams K, Muzzora C, Hunt PW, Siedner MJ. Brief Report: Higher ART Adherence Is Associated With Lower Systemic Inflammation in Treatment-Naive Ugandans Who Achieve Virologic Suppression. J Acquir Immune Defic Syndr 2018;77:507-13. [PMID: 29346185 DOI: 10.1097/QAI.0000000000001629] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
100 Kostadinova L, Shive CL, Anthony DD. Elevated Autotaxin and LPA Levels During Chronic Viral Hepatitis and Hepatocellular Carcinoma Associate with Systemic Immune Activation. Cancers (Basel) 2019;11:E1867. [PMID: 31769428 DOI: 10.3390/cancers11121867] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
101 Peterson TE, Baker JV. Assessing inflammation and its role in comorbidities among persons living with HIV. Curr Opin Infect Dis 2019;32:8-15. [PMID: 30461454 DOI: 10.1097/QCO.0000000000000510] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
102 Price JC, Wang R, Seaberg EC, Budoff MJ, Kingsley LA, Palella FJ, Witt MD, Post WS, Thio CL. The Association of Inflammatory Markers With Nonalcoholic Fatty Liver Disease Differs by Human Immunodeficiency Virus Serostatus. Open Forum Infect Dis 2017;4:ofx153. [PMID: 28929125 DOI: 10.1093/ofid/ofx153] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
103 Tibuakuu M, Zhao D, Saxena A, Brown TT, Jacobson LP, Palella FJ Jr, Witt MD, Koletar SL, Margolick JB, Guallar E, Korada SKC, Budoff MJ, Post WS, Michos ED. Low thigh muscle mass is associated with coronary artery stenosis among HIV-infected and HIV-uninfected men: The Multicenter AIDS Cohort Study (MACS). J Cardiovasc Comput Tomogr 2018;12:131-8. [PMID: 29396194 DOI: 10.1016/j.jcct.2018.01.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
104 Lacson JC, Barnes RP, Bahrami H. Coronary Artery Disease in HIV-Infected Patients: Downside of Living Longer. Curr Atheroscler Rep 2017;19:18. [PMID: 28265887 DOI: 10.1007/s11883-017-0651-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
105 Qi Q, Hua S, Clish CB, Scott JM, Hanna DB, Wang T, Haberlen SA, Shah SJ, Glesby MJ, Lazar JM, Burk RD, Hodis HN, Landay AL, Post WS, Anastos K, Kaplan RC. Plasma Tryptophan-Kynurenine Metabolites Are Altered in Human Immunodeficiency Virus Infection and Associated With Progression of Carotid Artery Atherosclerosis. Clin Infect Dis 2018;67:235-42. [PMID: 29415228 DOI: 10.1093/cid/ciy053] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
106 Okello S, Kim JH, Sentongo RN, Tracy R, Tsai AC, Kakuhikire B, Siedner MJ. Blood pressure trajectories and the mediated effects of body mass index and HIV-related inflammation in a mixed cohort of people with and without HIV in rural Uganda. J Clin Hypertens (Greenwich) 2019;21:1230-41. [PMID: 31278845 DOI: 10.1111/jch.13621] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
107 Schnittman SR, Byakwaga H, Boum Y, Kabakyenga J, Matthews LT, Burdo TH, Huang Y, Tracy RP, Haberer JE, Kembabazi A, Kaida A, Moisi D, Lederman MM, Bangsberg DR, Martin JN, Hunt PW. Changes in Immune Activation During Pregnancy and the Postpartum Period in Treated HIV Infection. Open Forum Infect Dis 2021;8:ofab245. [PMID: 34159218 DOI: 10.1093/ofid/ofab245] [Reference Citation Analysis]
108 Zungsontiporn N, Tello RR, Zhang G, Mitchell BI, Budoff M, Kallianpur KJ, Nakamoto BK, Keating SM, Norris PJ, Ndhlovu LC, Souza SA, Shikuma CM, Chow DC. Non-Classical Monocytes and Monocyte Chemoattractant Protein-1 (MCP-1) Correlate with Coronary Artery Calcium Progression in Chronically HIV-1 Infected Adults on Stable Antiretroviral Therapy. PLoS One 2016;11:e0149143. [PMID: 26867220 DOI: 10.1371/journal.pone.0149143] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 4.5] [Reference Citation Analysis]
109 Gootenberg DB, Paer JM, Luevano JM, Kwon DS. HIV-associated changes in the enteric microbial community: potential role in loss of homeostasis and development of systemic inflammation. Curr Opin Infect Dis 2017;30:31-43. [PMID: 27922852 DOI: 10.1097/QCO.0000000000000341] [Cited by in Crossref: 49] [Cited by in F6Publishing: 33] [Article Influence: 12.3] [Reference Citation Analysis]
110 Castillo-Mancilla JR, Cavassini M, Schneider MP, Furrer H, Calmy A, Battegay M, Scanferla G, Bernasconi E, Günthard HF, Glass TR; Swiss HIV Cohort Study . Association of Incomplete Adherence to Antiretroviral Therapy With Cardiovascular Events and Mortality in Virologically Suppressed Persons With HIV: The Swiss HIV Cohort Study. Open Forum Infect Dis 2021;8:ofab032. [PMID: 33604408 DOI: 10.1093/ofid/ofab032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
111 Ballocca F, Gili S, D'Ascenzo F, Marra WG, Cannillo M, Calcagno A, Bonora S, Flammer A, Coppola J, Moretti C, Gaita F. HIV Infection and Primary Prevention of Cardiovascular Disease: Lights and Shadows in the HAART Era. Prog Cardiovasc Dis 2016;58:565-76. [PMID: 26943980 DOI: 10.1016/j.pcad.2016.02.008] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 4.3] [Reference Citation Analysis]
112 Hanna DB, Guo M, Bůžková P, Miller TL, Post WS, Stein JH, Currier JS, Kronmal RA, Freiberg MS, Bennett SN, Shikuma CM, Anastos K, Li Y, Tracy RP, Hodis HN, Delaney JA, Kaplan RC. HIV Infection and Carotid Artery Intima-media Thickness: Pooled Analyses Across 5 Cohorts of the NHLBI HIV-CVD Collaborative. Clin Infect Dis 2016;63:249-56. [PMID: 27118787 DOI: 10.1093/cid/ciw261] [Cited by in Crossref: 33] [Cited by in F6Publishing: 37] [Article Influence: 5.5] [Reference Citation Analysis]
113 Chow FC, Ma Y, Manion M, Rupert A, Lambert-Messerlian G, Bushnell CD, Cedars MI, Sereti I, Sorond FA, Hsue PY, Tien PC. Factors associated with worse cerebrovascular function in aging women with and at risk for HIV. AIDS 2021;35:257-66. [PMID: 33229895 DOI: 10.1097/QAD.0000000000002755] [Reference Citation Analysis]
114 Temu TM, Zifodya JS, Polyak SJ, Wagoner J, Wanjalla CN, Masyuko S, Nyabiage J, Kinuthia J, Bloomfield GS, Page ST, Farquhar C. Antiretroviral therapy reduces but does not normalize immune and vascular inflammatory markers in adults with chronic HIV infection in Kenya. AIDS 2021;35:45-51. [PMID: 33055570 DOI: 10.1097/QAD.0000000000002729] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
115 Vassallo M, Durant J, Fabre R, Ticchioni M, Lotte L, Sindt A, Puchois A, De Monte A, Cezar R, Corbeau P, Pradier C. Switching to a Dual-Drug Regimen in HIV-Infected Patients Could Be Associated With Macrophage Activation? Front Med (Lausanne) 2021;8:712880. [PMID: 34458287 DOI: 10.3389/fmed.2021.712880] [Reference Citation Analysis]
116 Fitzpatrick ME, Nouraie M, Gingo MR, Camp D, Kessinger CJ, Sincebaugh JB, Clarke A, Ries JW, Kleerup EC, Kingsley L, Morris A. Novel relationships of markers of monocyte activation and endothelial dysfunction with pulmonary dysfunction in HIV-infected persons. AIDS 2016;30:1327-39. [PMID: 26990629 DOI: 10.1097/QAD.0000000000001092] [Cited by in Crossref: 32] [Cited by in F6Publishing: 21] [Article Influence: 6.4] [Reference Citation Analysis]
117 Schechter ME, Andrade BB, He T, Richter GH, Tosh KW, Policicchio BB, Singh A, Raehtz KD, Sheikh V, Ma D, Brocca-Cofano E, Apetrei C, Tracy R, Ribeiro RM, Sher A, Francischetti IMB, Pandrea I, Sereti I. Inflammatory monocytes expressing tissue factor drive SIV and HIV coagulopathy. Sci Transl Med 2017;9:eaam5441. [PMID: 28855397 DOI: 10.1126/scitranslmed.aam5441] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 11.0] [Reference Citation Analysis]
118 Nou E, Lu MT, Looby SE, Fitch KV, Kim EA, Lee H, Hoffmann U, Grinspoon SK, Lo J. Serum oxidized low-density lipoprotein decreases in response to statin therapy and relates independently to reductions in coronary plaque in patients with HIV. AIDS 2016;30:583-90. [PMID: 26558731 DOI: 10.1097/QAD.0000000000000946] [Cited by in Crossref: 35] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
119 Chandra D, Gupta A, Fitzpatrick M, Haberlen SA, Neupane M, Leader JK, Kingsley LA, Kleerup E, Budoff MJ, Witt M, Sciurba FC, Post WS, Morris A. Lung Function, Coronary Artery Disease, and Mortality in HIV. Ann Am Thorac Soc 2019;16:687-97. [PMID: 31113229 DOI: 10.1513/AnnalsATS.201807-460OC] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]